1296589

Robinson S

1992

Which hormone tests for the diagnosis of polycystic ovary syndrome?

1298870

Barletta C

1992

[The role of the endogenous opioid system in the pathogenesis of polycystic ovary syndrome: the altered neuroendocrine regulation of GnRH-LH is corrected after clomiphene therapy].

1302841

Kalinin AP

1992

[UV-irradiation of the blood in the treatment of polycystic ovary syndrome].

1302842

Shilin DE

1992

[Difficulties in the diagnosis and treatment of infertility caused by the combination of microprolactinoma and polycystic ovaries].

1302975

Skiba VV

1992

[Simultaneous operation in a female patient with hepatic echinococcosis, calculous cholecystitis, umbilical hernia, uterine fibromyoma and polycystic ovaries].

1303925

Baron J

1992

[Surgical treatment of polycystic ovary syndrome. A. Preoperative examinations].

1303926

Baron J

1992

[Surgical treatment of polycystic ovary syndrome. B. Postoperative examinations].

1303927

Jakimiuk A

1992

[FAI in hirsutism of women with polycystic ovary syndrome].

1305145

Ostrze?ski A

1992

[Video-laparoscopic treatment of polycystic ovaries using monopolar electrocoagulation].

1305574

Szymanowski K

1992

[Laparoscopy in diagnosis and treatment of polycystic ovaries].

1306514

Dewailly D

1992

Insulin resistance and polycystic ovarian syndrome.

1319000

Ehrmann DA

1992

Detection of functional ovarian hyperandrogenism in women with androgen excess.

1321739

Lanzone A

1992

Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion.

1322430

Ciaraldi TP

1992

Cellular mechanisms of insulin resistance in polycystic ovarian syndrome.

1325578

Hallak M

1992

Mullerian adenosarcoma of the uterus with sarcomatous overgrowth.

1330379

Turner EI

1992

Investigation of adrenal function in women with oligomenorrhoea and hirsutism (clinical PCOS) from the north-east of England using an adrenal stimulation test.

1331938

Urban RJ

1992

Endocrine control of steroidogenesis in granulosa cells.

1332475

Uemura T

1992

Mechanisms involved in the pituitary desensitization induced by gonadotropin-releasing hormone agonists.

1332986

Smitz J

1992

The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres.

1333923

Perricone R

1992

Cystic ovaries in women affected with hereditary angioedema.

1336918

Dahlgren E

1992

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women.

1342461

Devoto L

1992

[Polycystic ovaries].

1343754

Vitale F

1992

LHRH analogues and PCO disease: validity of the use of enantone depot in the treatment of the disease.

1349592

Yoshino K

1992

Further evidence concerning catecholamine metabolism in polycystic ovary syndrome following Gn-RH administration.

1349593

Harracksingh C

1992

Comparison of the adrenocorticotropic hormone stimulation test in the follicular and luteal phases of the menstrual cycle.

1354209

Takahashi K

1992

On the relationship between endocrine and ovulatory abnormalities, and polycystic ovaries as diagnosed by ultrasonography.

1355760

Cataldo NA

1992

Ovarian pregnancy in polycystic ovary syndrome: a case report.

1355764

Hamori M

1992

Androgen response in polycystic ovarian syndrome to FSH treatment after LHRH agonist suppression.

1355813

McCluskey SE

1992

Binge-eating and polycystic ovaries.

1357394

Donderwinkel PF

1992

Pregnancy after induction of ovulation with recombinant human FSH in polycystic ovary syndrome.

1358175

Howard JS 3rd

1992

Severe psychosis and the adrenal androgens.

1358838

Kubota T

1992

Combined therapy with bromocriptine and clomiphene citrate for patients with normoprolactinemic amenorrhea.

1358841

Takahashi K

1992

Prevalence of polycystic ovaries by transvaginal ultrasound and serum androgens.

1358842

Ostrzenski A

1992

Endoscopic carbon dioxide laser ovarian wedge resection in resistant polycystic ovarian disease.

1363150

Faglia G

1992

[Therapeutic use of somatostatin analogues in endocrinology].

1364511

Bednarek-Tupikowska G

1991

Lipid disturbances in women with polycystic ovary syndrome.

1365059

Mici? DD

1992

[Polycystic ovary disease: clinical picture, diagnosis and methods of therapy].

1371292

Cataldo NA

1992

Follicular fluid insulin-like growth factor binding protein profiles in polycystic ovary syndrome.

1383254

San Roman GA

1992

Insulin-like growth factor binding proteins in ovarian follicles from women with polycystic ovarian disease: cellular source and levels in follicular fluid.

1387653

Matteri RK

1992

The ovarian contribution to peripherally derived serum C19 conjugates.

1387880

Abdel Gadir A

1992

Implications of ultrasonically diagnosed polycystic ovaries. II. Studies of dynamic and pulsatile hormonal patterns.

1387937

Nduwayo L

1992

[Primary amenorrhea revealing micropolycystic ovary syndrome].

1394482

Kobilkov? J

1992

[Results of surgical treatment of ovarian dysfunction].

1395061

McKeigue P

1992

Are women with polycystic ovary syndrome at special risk for coronary heart disease?

1395062

Conway GS

1992

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

1395063

Clayton RN

1992

How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?

1397698

Dunaif A

1992

Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome.

1397946

Naether O

1992

[Spontaneous conception after laparoscopic coagulation of the ovarian surfaces in a patient with primary normogonadotropic hyperandrogenemic amenorrhea].

1400931

Dale PO

1992

Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.

1414558

Sinisi L

1992

Sneddon's syndrome, anticardiolipin antibodies and anticardiolipin cofactor. A case report.

1415155

Toniolo P

1992

Re: Polycystic ovaries and the risk of breast cancer.

1424178

Taylor R

1992

Post-prandial thermogenesis and insulin sensitivity in the polycystic ovary syndrome.

1424179

Robinson S

1992

Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance.

1424181

Pache TD

1992

17 beta-Oestradiol, androstenedione and inhibin levels in fluid from individual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals.

1426306

Nobels F

1992

Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis.

1426312

Anttila L

1992

Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries.

1426314

Miles RA

1992

Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women.

1426315

Owen EJ

1992

11 beta-hydroxyandrostenedione in plasma, follicular fluid, and granulosa cells of women with normal and polycystic ovaries.

1427640

Dunaif A

1992

Adrenal disorders and polycystic ovary syndrome.

1430129

Falcone T

1992

Impaired glucose effectiveness in patients with polycystic ovary syndrome.

1438600

Matsunaga H

1992

[Gonadal function in young female affective illness associated with the menstrual cycle--in relation to the polycystic ovary syndrome].

1442911

Zalel Y

1992

Spontaneous ovarian hyperstimulation syndrome concomitant with spontaneous pregnancy in a woman with polycystic ovary disease.

1444176

Dewailly D

1992

[Insulin resistance and polycystic ovary syndrome].

1446395

Garzetti GG

1992

A case of segmental renal dysplasia incidentally discovered in an 18 year old woman during a gynecological surgical operation.

1448386

Smyczek-Gargya B

1992

Endometrial cancer associated with polycystic ovaries in young women.

1450154

Fox R

1992

Which hormone tests for the diagnosis of polycystic ovary syndrome.

1467663

Vytiska-Binstorfer E

1992

[The endocrine status of young girls].

1471701

Ober C

1992

Increased risk for polycystic ovary syndrome associated with human leukocyte antigen DQA1*0501.

1471702

Carmina E

1992

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

1471704

Carmina E

1992

Increased circulating levels of immunoreactive beta-endorphin in polycystic ovary syndrome is not caused by increased pituitary secretion.

1473080

McSherry J

1992

Bulimia nervosa and acne.

1476233

Alieva EA

1992

[Diagnostic and surgical laparoscopy in polycystic ovary syndrome].

1478628

Cisternino M

1992

Final height attainment and gonadal function in girls with precocious puberty treated with cyproterone acetate.

1478997

Yoshino K

1992

Endocrinological environment with regard to the number of microcysts in patients with polycystic ovary syndrome.

1479563

Fulghesu AM

1992

Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.

1480591

Atamanova TM

1992

[Interrelationships between prolactin and the renin-aldosterone system in patients with various endocrine diseases].

1480757

Bray GA

1992

Genetic, hypothalamic and endocrine features of clinical and experimental obesity.

1482200

Wolf AS

1992

[Ovarian cysts in childhood, puberty and adolescence].

1486695

Fauser BC

1992

The significance of a single serum LH measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates.

1490653

Prelevi? GM

1992

Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries.

1492584

Buckler HM

1992

Vaginal progesterone administration in physiological doses normalizes raised luteinizing hormone levels in patients with polycystic ovarian syndrome.

1495451

Esposito V

1992

[Correlation between hormonal and metabolic profiles in women with polycystic ovary syndrome].

1500491

Falsetti L

1992

Treatment of moderate and severe hirsutism with a gonadotrophin-releasing hormone agonist.

1509712

Hrnciar J

1992

[Clinical manifestations of insulin resistance. The hormonal-metabolic syndrome X (5H), its prevalence and impact on cardiovascular morbidity and mortality. I].

1509713

Hrnciar J

1992

[Hyperinsulinism as a major etiopathogenic link with arterial hypertension, hyperlipoproteinemia and hirsutism. II].

1511766

Scheele F

1992

Severe ovarian hyperstimulation: a case report and essentials of prevention and management.

1518438

Prelevi? GM

1992

Effects of the somatostatin analogue, octreotide, in polycystic ovary syndrome.

1518441

von Werder K

1992

Potential indications for octreotide in endocrinology.

1521640

Dale PO

1992

Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations.

1521660

McClure N

1992

Body weight, body mass index, and age: predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome?

1522185

Abdel Gadir A

1992

Implications of ultrasonically diagnosed polycystic ovaries. I. Correlations with basal hormonal profiles.

1523941

Kamada T

1992

[A case of insulin receptor abnormality (type A)].

1529129

Sutton CL

1992

Ovarian masses revisited: radiologic and pathologic correlation.

1530464

Marsh M

1992

Update on endocrinology.

1531200

Dor J

1992

The effect of gonadotropin-releasing hormone agonist on the ovarian response and in vitro fertilization results in polycystic ovarian syndrome: a prospective study.

1531463

Cedars MI

1992

Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction.

1531466

Marcondes JA

1992

Treatment of hirsutism in women with flutamide.

1532906

Holownia P

1992

Studies to confirm the source of 11 beta-hydroxyandrostenedione.

1533088

Grimes DA

1992

Frontiers of operative laparoscopy: a review and critique of the evidence.

1533185

Toscano V

1992

Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.